Abstract
Disease and drug-related alterations in the brain membrane proteome are of particular interest for investigations into neuropsychiatric disorders. Despite decades of research into neurotransmitters and their receptors, our understanding of complex neuropsychiatric disorders has failed to advance substantially. Therefore, global membrane protein profiling studies that are non-hypothesis driven and exploratory are a complementary approach to elucidate the underlying pathomechanisms associated with psychiatric disorders. Although membrane proteins play critical roles in almost all cellular processes, their unique biochemical properties have challenged current quantitative proteomics approaches. The aim of the present review is to critically evaluate and discuss the use and applicability of current quantitative proteomic platforms, sample preparation methods and statistical tools in view of their application to membrane proteome analysis of brain tissue.
Keywords: Neuropsychiatric disorders, quantitative proteomics, membrane proteins, brain tissue
Current Proteomics
Title: Quantitative Proteomic Approaches to Investigate the Membrane Proteome in Neuropsychiatric Disorders
Volume: 4 Issue: 3
Author(s): Man K. Chan and Sabine Bahn
Affiliation:
Keywords: Neuropsychiatric disorders, quantitative proteomics, membrane proteins, brain tissue
Abstract: Disease and drug-related alterations in the brain membrane proteome are of particular interest for investigations into neuropsychiatric disorders. Despite decades of research into neurotransmitters and their receptors, our understanding of complex neuropsychiatric disorders has failed to advance substantially. Therefore, global membrane protein profiling studies that are non-hypothesis driven and exploratory are a complementary approach to elucidate the underlying pathomechanisms associated with psychiatric disorders. Although membrane proteins play critical roles in almost all cellular processes, their unique biochemical properties have challenged current quantitative proteomics approaches. The aim of the present review is to critically evaluate and discuss the use and applicability of current quantitative proteomic platforms, sample preparation methods and statistical tools in view of their application to membrane proteome analysis of brain tissue.
Export Options
About this article
Cite this article as:
Chan K. Man and Bahn Sabine, Quantitative Proteomic Approaches to Investigate the Membrane Proteome in Neuropsychiatric Disorders, Current Proteomics 2007; 4 (3) . https://dx.doi.org/10.2174/157016407783221321
DOI https://dx.doi.org/10.2174/157016407783221321 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Computational Study of Human Tyrosine Hydroxylase Mutants to Uphold [4-(Propan-2-yl) Phenyl]Carbamic Acid as a Potential Inhibitor
CNS & Neurological Disorders - Drug Targets Ivabradine: Cardiovascular Effects
Recent Patents on Cardiovascular Drug Discovery Commentary (Research Highlights: TRPV-ing up Pain for a Long Life)
CNS & Neurological Disorders - Drug Targets Inflammatory Pain: The Cellular Basis of Heat Hyperalgesia
Current Neuropharmacology Psychopathological Behaviour and Cognition in Morbid Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Pre-attentive Visual Processing in Alzheimer’s Disease: An Event-related Potential Study
Current Alzheimer Research Combination of P300 and CSF β-Amyloid(1-42) Assays May Provide a Potential Tool in the Early Diagnosis of Alzheimers Disease
Current Alzheimer Research Quorum Sensing Inhibitors from the Sea: Lessons from Marine Symbiotic Relationships
Current Organic Chemistry Role of Flavonoids in Neurodegenerative Diseases: Limitations and Future Perspectives
Current Topics in Medicinal Chemistry Potential Therapeutics for Vascular Cognitive Impairment and Dementia
Current Neuropharmacology Restless Leg Syndrome Associated with Atypical Antipsychotics: Current Status, Pathophysiology, and Clinical Implications
Current Drug Safety Plasma Clusterin as a Potential Biomarker for Alzheimer’s Disease-A Systematic Review and Meta-analysis
Current Alzheimer Research Vasopressin Secretion Control: Central Neural Pathways, Neurotransmitters and Effects of Drugs
Current Pharmaceutical Design Intestinal Permeability in Non-alcoholic Fatty LIVER Disease: The Gut-liver Axis
Reviews on Recent Clinical Trials The Neuropsychopharmacology of Pathological Gambling
Current Psychiatry Reviews Investigation Binding Patterns of Human Carboxylesterase I (hCES I) with Broad Substrates by MD Simulations
Current Topics in Medicinal Chemistry Homocysteine and Non-Cardiac Vascular Disease
Current Pharmaceutical Design Link Between Chronic Bacterial Inflammation and Alzheimer Disease
CNS & Neurological Disorders - Drug Targets Nociceptin/Orphanin FQ Peptide Receptor as a Therapeutic Target for Obesity
Mini-Reviews in Medicinal Chemistry The Role of HLA Promoters in Autoimmunity
Current Pharmaceutical Design